News
-
-
PRESS RELEASE
A 1st half-year 2024 marked by the success of the commercial relaunch and the strengthening of strategic alliances
Fermentalg presents strong 1st half-year 2024 results with a 2.7-fold increase in sales. Strategic partnerships boost sales and manufacturing performance. Cash position up by €10 million -
-
-
-
-
-
PRESS RELEASE
Thanks to sales of EUR6.3 million, Fermentalg closes a historic 1st half-year 2024, also marked by its strategic agreement with HuvePharma
Fermentalg reports strong sales growth in H1 2024, exceeding targets. Partners with HuvePharma for sustainable solutions. Annual sales target raised to €12M. Strategic alliance for a competitive, sustainable supply -
-